Search research articles
Contact Us
Filters
Showing results (121-130 of 743) with videos related to
Page
of 75
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 20, 2023
Immune-Related Sclerosing Cholangitis and Subsequent Pyogenic Liver Abscesses in Two Patients With Melanoma Treated by Triplet Therapy: A Case Report
Viola Schön, Daniel Stocker, Christoph Jüngst, et al.
Melanoma Research
|
April 27, 2016
Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation
Benjamin Henning, Pascale Stieger, Jivko Kamarachev, et al.
Melanoma Research
|
June 2, 2017
Interstitial granulomatous dermatitis during talimogen laherparepvec treatment
Anna L Frauchiger, Marie-Charlotte Brüggen, Simone M Goldinger, et al.
Melanoma Research
|
December 18, 2018
Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma
Florentia Dimitriou, Joanna Mangana, Sara Micaletto, et al.
International Journal of Dermatology
|
March 15, 2006
Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome
Sonja Michaelis, Dmitry V Kazakov, Günter Burg, et al.
JAMA Oncology
|
September 24, 2020
Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A Review
Reinhard Dummer, Paolo A Ascierto, Paul Nathan, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
June 25, 2016
A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines
Laurence Imhof, Reinhard Dummer, Jil Dreier, et al.
Chemical Immunology and Allergy
|
May 23, 2012
Cutaneous drug eruptions associated with the use of new oncological drugs
Benedetta Belloni, Nicola Schönewolf, Sima Rozati, et al.
Expert Opinion on Pharmacotherapy
|
January 27, 2022
Advances in the drug management of basal cell carcinoma
Egle Ramelyte, Gaetana Restivo, Maria Mannino, et al.
Cancer Treatment Reviews
|
July 4, 2020
Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications
Daniela Massi, Daniela Mihic-Probst, Dirk Schadendorf, et al.
Page
of 75
Search research articles
Search
Showing results (121-130 of 743) with videos related to
Sort By:
Page
of 75
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 20, 2023
Immune-Related Sclerosing Cholangitis and Subsequent Pyogenic Liver Abscesses in Two Patients With Melanoma Treated by Triplet Therapy: A Case Report
Viola Schön, Daniel Stocker, Christoph Jüngst, et al.
Melanoma Research
|
April 27, 2016
Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation
Benjamin Henning, Pascale Stieger, Jivko Kamarachev, et al.
Melanoma Research
|
June 2, 2017
Interstitial granulomatous dermatitis during talimogen laherparepvec treatment
Anna L Frauchiger, Marie-Charlotte Brüggen, Simone M Goldinger, et al.
Melanoma Research
|
December 18, 2018
Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma
Florentia Dimitriou, Joanna Mangana, Sara Micaletto, et al.
International Journal of Dermatology
|
March 15, 2006
Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome
Sonja Michaelis, Dmitry V Kazakov, Günter Burg, et al.
JAMA Oncology
|
September 24, 2020
Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A Review
Reinhard Dummer, Paolo A Ascierto, Paul Nathan, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
June 25, 2016
A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines
Laurence Imhof, Reinhard Dummer, Jil Dreier, et al.
Chemical Immunology and Allergy
|
May 23, 2012
Cutaneous drug eruptions associated with the use of new oncological drugs
Benedetta Belloni, Nicola Schönewolf, Sima Rozati, et al.
Expert Opinion on Pharmacotherapy
|
January 27, 2022
Advances in the drug management of basal cell carcinoma
Egle Ramelyte, Gaetana Restivo, Maria Mannino, et al.
Cancer Treatment Reviews
|
July 4, 2020
Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications
Daniela Massi, Daniela Mihic-Probst, Dirk Schadendorf, et al.
Page
of 75